Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Asian Pacific Journal of Allergy and Immunology|March 23, 2004
Determination of laboratory reference ranges for lymphocyte immunophenotype subsets in healthy adult Japanese using flow cytometryH Kyle Webster, Yohko Kawai, Douslas Haney, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|December 22, 2017
Structural Organization of 6B9 Molecule, a Monoclonal Antibody Against LycopeneIvan M Petyaev, Konstantin P Alekseev, Valeriy V Tsibezov, et al.
Molecular Cancer Therapeutics|May 23, 2024
Radiation and Chemo-Sensitizing Effects of DNA-PK Inhibitors Are Proportional in Tumors and Normal TissuesJennifer H E Baker, Alastair H Kyle, Nannan A Liu, et al.
Journal of Materials Science. Materials in Medicine|August 21, 2008
The use of dual beam ESEM FIB to reveal the internal ultrastructure of hydroxyapatite nanoparticle-sugar-glass compositesDavid M Wright, John J Rickard, Nigel H Kyle, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Factor Structure of the Postpartum Bonding Questionnaire in a US-Based Cohort of MothersAndréane Lavallée, Jennifer M Warmingham, Mark A Reimers, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 30, 2025
Factors Associated with Low-Dose Tamoxifen Use Among Women with Atypical Hyperplasia, Lobular or Ductal Carcinoma In SituMaya S Deshmukh, Margaret H Kyle, Peter J Zeiger, et al.
Plos One|November 9, 2013
Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxinJennifer H E Baker, Alastair H Kyle, Kirsten L Bartels, et al.
Scientifica|September 27, 2017
Lycopene Inhibits Propagation of Chlamydia InfectionNaylia A Zigangirova, Elena Y Morgunova, Elena D Fedina, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|June 15, 2018
Non-Invasive Immunofluorescence Assessment of Lycopene Supplementation Status in Skin SmearsIvan M Petyaev, Naylia A Zigangirova, Dmitry Pristensky, et al.
Cancer Research|November 15, 2012
Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibitionChristopher Daly, Alexandra Eichten, Carla Castanaro, et al.
Pageof 10